Litcius/Paper detail

Cortical bone stem cells modify cardiac inflammation after myocardial infarction by inducing a novel macrophage phenotype

Alexander R. H. Hobby, Remus M. Berretta, Deborah Eaton, Hajime Kubo, Eric Feldsott, Yijun Yang, Alaina L. Headrick, Keith A. Koch, Marcello Rubino, Justin Kurian, Mohsin Khan, Yinfei Tan, Sadia Mohsin, Stefania Gallucci, Timothy A. McKinsey, Steven R. Houser

2021American Journal of Physiology-Heart and Circulatory Physiology27 citationsDOIOpen Access PDF

Abstract

Cortical bone stem cell (CBSC) therapy after myocardial infarction alters the inflammatory response to cardiac injury. We found that cortical bone stem cell therapy induces a unique macrophage phenotype in vitro and can modulate macrophage/fibroblast cross talk.

Topics & Concepts

InflammationPhenotypeStem cellMacrophageMyocardial infarctionMedicineInternal medicineCardiologyNeurosciencePathologyBiologyCell biologyIn vitroGeneBiochemistryCardiac Fibrosis and RemodelingMacrophage Migration Inhibitory FactorCardiac and Coronary Surgery Techniques
Cortical bone stem cells modify cardiac inflammation after myocardial infarction by inducing a novel macrophage phenotype | Litcius